Artivion | CRY - Debt


Artivion reported $317.78M in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.78M 1.6M Mar/2026
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 2.04B 6.27M Mar/2026
J&J USD 54.99B 7.05B Mar/2026
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Pfizer USD 63.19B 536M Jun/2026
ResMed USD 843.17M 4.55M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
Terumo JPY 379.8B 219.92B Mar/2026
Trinity Biotech USD 137.98M 37.22M Dec/2025